9 Mar 2022 , 01:33 AM
Panacea Biotec announced that the asset purchase agreement has been executed on 28 February 2022 for the sale of pharmaceutical formulation brands of the companys material subsidiary Panacea Biotech Pharma in India and Nepal to Mankind Pharma for an aggregate consideration of Rs 1827 crore
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.